Veracyte, Inc. (VCYT) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
Veracyte (VCYT) Q2 2026: Prosigna Launch and 20% Decipher Growth Signal Expanding Oncology Franchise
July 31, 2026
-
Veracyte (VCYT) Q1 2026: Decipher Volumes Up 24% as Major Launches Set Stage for Next Growth Cycle
May 06, 2026
-
Veracyte (VCYT) Q4 2025: Decipher 21% Volume Growth Anchors 2026 Double-Digit Guidance
February 26, 2026
-
Veracyte (VCYT) Q3 2025: Decipher Volumes Up 26% as Margin Surges 650bps, Fueling Pipeline Acceleration
November 05, 2025
-
Veracyte (VCYT) Q2 2025: Decipher Volume Surges 28%, Anchoring Multi-Year Growth Trajectory
August 06, 2025
-
Veracyte (VCYT) Q1 2025: Decipher Volumes Jump 37% as Metastatic Launch Expands Prostate Franchise
July 04, 2025